Reagents and consumables
Ended Awarded
- Contract number
- 75N91023F00013
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,540
Award facts
- Contract value 100% obligated
- $22,539.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation was awarded a $22,539.59 firm fixed price delivery order for reagents and consumables by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract has no set-aside designation and requires completion by July 6, 2023. Roche will provide the requested products to support research efforts at the specified place of performance in Castleton, Indiana. No major subcontractors were identified.
Quick answers
Who was awarded contract 75N91023F00013?
75N91023F00013 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on June 7, 2023.
How much is contract 75N91023F00013 worth?
The government has obligated $22,540 on 75N91023F00013.
Is contract 75N91023F00013 an order under another contract?
Yes. 75N91023F00013 is a delivery order under 75N91019D00038, an indefinite delivery contract.
Was contract 75N91023F00013 competed?
The extent of competition for 75N91023F00013 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award